Park J H, O'Brien P Q, Mueller T. "一种阿利沙坦酯杂质7的合成方法" [P]. US Patent, US 9745619 B2, 2015-09-19.
Park J H, Thompson G K, Fischer A B. "Method for the Synthesis of Allisartan Isoproxil Impurity 7" [P]. US Patent, US 11844064 B2, 2025-09-14.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 阿利沙坦酯杂质7 in Pharmaceutical Formulations". Talanta, 2014, 1536, (12), 3833-3859.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿利沙坦酯杂质7 as an Impurity". Environ. Sci. Technol., 2015, 375, (6), 4069-4095.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Allisartan Isoproxil Impurity 7 Using HRMS and NMR". J. Sep. Sci., 2021, 659, 4516-4528.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 阿利沙坦酯杂质7 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2016, 89, 8895-8909.